Cargando…
A transition from the BPharm to the PharmD degree in five selected countries
This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand. The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. Ho...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763299/ https://www.ncbi.nlm.nih.gov/pubmed/31592299 http://dx.doi.org/10.18549/PharmPract.2019.3.1611 |
_version_ | 1783454180782899200 |
---|---|
author | Supapaan, Teeraporn Low, Bee Y. Wongpoowarak, Payom Moolasarn, Summana Anderson., Claire |
author_facet | Supapaan, Teeraporn Low, Bee Y. Wongpoowarak, Payom Moolasarn, Summana Anderson., Claire |
author_sort | Supapaan, Teeraporn |
collection | PubMed |
description | This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand. The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme that are designed to meet the needs of their countries. Each country created a different process to handle the transition to an all-PharmD programme, but mostly had the process of school accreditation mandated by the regulatory bodies. The main barrier to the transition in most of the countries was the issue of educational quality. A set of indicators is needed to measure and monitor the impact/outcome of the PharmD degree. Each country has different needs due to the different contexts of health care systems and the scope of pharmacy practice. In order to increase their chances of benefiting from the new programme, academic leaders should critically assess their countries’ needs before deciding to adopt a PharmD programme. |
format | Online Article Text |
id | pubmed-6763299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Centro de Investigaciones y Publicaciones Farmaceuticas |
record_format | MEDLINE/PubMed |
spelling | pubmed-67632992019-10-07 A transition from the BPharm to the PharmD degree in five selected countries Supapaan, Teeraporn Low, Bee Y. Wongpoowarak, Payom Moolasarn, Summana Anderson., Claire Pharm Pract (Granada) Review This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand. The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme that are designed to meet the needs of their countries. Each country created a different process to handle the transition to an all-PharmD programme, but mostly had the process of school accreditation mandated by the regulatory bodies. The main barrier to the transition in most of the countries was the issue of educational quality. A set of indicators is needed to measure and monitor the impact/outcome of the PharmD degree. Each country has different needs due to the different contexts of health care systems and the scope of pharmacy practice. In order to increase their chances of benefiting from the new programme, academic leaders should critically assess their countries’ needs before deciding to adopt a PharmD programme. Centro de Investigaciones y Publicaciones Farmaceuticas 2019 2019-08-21 /pmc/articles/PMC6763299/ /pubmed/31592299 http://dx.doi.org/10.18549/PharmPract.2019.3.1611 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Supapaan, Teeraporn Low, Bee Y. Wongpoowarak, Payom Moolasarn, Summana Anderson., Claire A transition from the BPharm to the PharmD degree in five selected countries |
title | A transition from the BPharm to the PharmD degree in five selected
countries |
title_full | A transition from the BPharm to the PharmD degree in five selected
countries |
title_fullStr | A transition from the BPharm to the PharmD degree in five selected
countries |
title_full_unstemmed | A transition from the BPharm to the PharmD degree in five selected
countries |
title_short | A transition from the BPharm to the PharmD degree in five selected
countries |
title_sort | transition from the bpharm to the pharmd degree in five selected
countries |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763299/ https://www.ncbi.nlm.nih.gov/pubmed/31592299 http://dx.doi.org/10.18549/PharmPract.2019.3.1611 |
work_keys_str_mv | AT supapaanteeraporn atransitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT lowbeey atransitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT wongpoowarakpayom atransitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT moolasarnsummana atransitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT andersonclaire atransitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT supapaanteeraporn transitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT lowbeey transitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT wongpoowarakpayom transitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT moolasarnsummana transitionfromthebpharmtothepharmddegreeinfiveselectedcountries AT andersonclaire transitionfromthebpharmtothepharmddegreeinfiveselectedcountries |